Related Experiment Video
Updated: May 8, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack
Alexander M Scherbakov1, Lidia B Stefanova, Danila V Sorokin
1Laboratory of Clinical Biochemistry, Institute of Clinical Oncology, N.N. Blokhin Cancer Research Centre, Kashirskoye sh. 24, Moscow 115478, Russia.
Abstract:
The tolerance of cancer cells to hypoxia depends on the combination of different factors--from increase of glycolysis (Warburg Effect) to activation of intracellular growth/apoptotic pathways. Less is known about the influence of epithelial-mesenchymal transition (EMT) and EMT-associated pathways on the cell sensitivity to hypoxia. The aim of this study was to explore the role of Snail signaling, one of the key EMT pathways, in the mediating of hypoxia response and regulation of cell sensitivity to hypoxia, using as a model in vitro cultured breast cancer cells. Earlier we have shown that estrogen-independent HBL-100 breast cancer cells differ from estrogen-dependent MCF-7 cells with increased expression of Snail1, and demonstrated Snail1 involvement into formation of hormone-resistant phenotype. Because Snail1 belongs to hypoxia-activated proteins, here we studied the influence of Snail1 signaling on the cell tolerance to hypoxia. We found that Snail1-enriched HBL-100 cells were less sensitive to hypoxia-induced growth suppression if compared with MCF-7 line (31% MCF-7 vs. 71% HBL-100 cell viability after 1% O2 atmosphere for 3 days). Snail1 knock-down enhanced the hypoxia-induced inhibition of cell proliferation giving the direct evidence of Snail1 involvement into cell protection from hypoxia attack. The protective effect of Snail1 was shown to be mediated, at least in a part, via beta-catenin which positively regulated expression of HIF-1-dependent genes. Finally, we found that cell tolerance to hypoxia was accompanied with the failure in the phosphorylation of AMPK - the key energy sensor, and demonstrated an inverse relationship between AMPK and Snail/beta-catenin signaling. Totally, our data show that Snail1 and beta-catenin, besides association with loss of hormone dependence, protect cancer cells from hypoxia and may serve as an important target in the treatment of breast cancer. Moreover, we suggest that the level of these proteins as well the level of AMPK phosphorylation may be considered as predictors of the tumor sensitivity to anti-angiogenic drugs.
Insights
Snail1 and beta-catenin protect breast cancer cells from hypoxia by regulating growth and apoptotic pathways. These proteins, along with AMPK phosphorylation levels, may predict tumor response to anti-angiogenic drugs.
Area of Science:
- Cancer Biology
- Molecular Oncology
- Cellular Signaling
Background:
- Hypoxia tolerance in cancer involves glycolysis and growth pathways, but the role of epithelial-mesenchymal transition (EMT) remains less understood.
- Snail1 is a key EMT pathway protein known to be activated by hypoxia and involved in hormone resistance in breast cancer cells.
- Estrogen-independent HBL-100 cells exhibit higher Snail1 expression than estrogen-dependent MCF-7 cells.
Purpose of the Study:
- To investigate the role of Snail signaling in mediating hypoxia response and regulating breast cancer cell sensitivity to hypoxia.
- To explore the protective mechanisms of Snail1 against hypoxia-induced growth suppression.
- To examine the relationship between Snail/beta-catenin signaling, AMPK activity, and hypoxia tolerance.
Main Methods:
- In vitro culture of HBL-100 and MCF-7 breast cancer cell lines under normoxic and hypoxic conditions (1% O2).
- Snail1 knockdown using RNA interference.
- Analysis of cell viability, proliferation, beta-catenin levels, HIF-1-dependent gene expression, and AMPK phosphorylation.
- Comparison of protein expression and signaling pathways between Snail1-enriched and control cell lines.
Main Results:
- Snail1-enriched HBL-100 cells showed significantly higher viability (71%) under hypoxia compared to MCF-7 cells (31%).
- Snail1 knockdown increased hypoxia-induced growth inhibition, confirming Snail1's protective role.
- Snail1's protective effect was partly mediated by beta-catenin, which positively regulated HIF-1-dependent genes.
- Hypoxia tolerance correlated with decreased AMPK phosphorylation, indicating an inverse relationship with Snail/beta-catenin signaling.
Conclusions:
- Snail1 and beta-catenin protect breast cancer cells from hypoxia, independent of hormone dependence.
- These proteins represent potential therapeutic targets for overcoming hypoxia-driven resistance in breast cancer.
- AMPK phosphorylation levels, alongside Snail1 and beta-catenin expression, may serve as predictive biomarkers for anti-angiogenic therapy response.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Hedgehog Signaling Pathway

